| Low-risk group (n = 225) | High-risk group (n = 73) | p-value |
---|---|---|---|
Sex | Â | Â | 0.57 |
 Male | 144 (64) | 44 (60.3) |  |
 Female | 81 (36) | 29 (39.7) |  |
Ethnicity | Â | Â | 0.32 |
 White | 162 (72.0) | 60 (82.2) |  |
 S. Asian | 38 (16.9) | 8 (11.0) |  |
 Black | 23 (10.2) | 4 (5.5) |  |
 Others | 2 (0.9) | 1 (1.4) |  |
Age | Â | Â | 0.24 |
 Mean ± SD | 50.2 ± 13.6 | 51.6 ± 14.1 |  |
 Range | 19.4–74.2 | 20.0–73.1 |  |
Donor type | |||
 Living | 89 (39.6) | 38 (52.1) | 0.06 |
 DBD | 95 (42.2) | 31 (42.5) | 0.96 |
 DCD | 41 (18.2) | 4 (5.5) | 0.008 |
Length of follow up (days) | |||
 Mean ± SD | 539.7 ± 20.4 | 691.5 ± 38.5 | < 0.01 (95%CI |
 Range | 51–1139 | 139–1181 | 144–158) |
Primary renal diagnosis | |||
 Diabetes mellitus | 16 (7.1) | 1 (1.4) | 0.07 |
 Glomerulonephritis | 76 (33.8) | 24 (32.9) | 0.88 |
 Pyelonephritis | 21 (9.3) | 8 (11.0) | 0.67 |
 Hypertension | 13 (5.8) | 3 (4.1) | 0.57 |
 Autosomal dominant polycystic kidney | 37 (16.4) | 11 (15.1) | 0.79 |
 Renal vascular disease | 12 (5.3) | 2 (2.7) | 0.36 |
 Other | 21 (9.3) | 12 (16.4) | 0.09 |
 Uncertain aetiology | 29 (12.9) | 12 (16.4) | 0.45 |
HLA | |||
MM | 3.17 (1.55) | 3.12 (1.24) | 0.22 |